o-Carboxamidodiphenylsulfon | 66728-54-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: o-Carboxamidodiphenylsulfon
• 英文别名: 2-benzenesulfonyl-benzoic acid amide；2-Phenylsulfon-benzamid；2-Benzolsulfonyl-benzoesaeure-amid；Diphenylsulfon-carbonsaeure-(2)-amid；Benzenesulfonylbenzamide；2-(benzenesulfonyl)benzamide
• CAS: 66728-54-9
• 化学式: C₁₃H₁₁NO₃S
• 分子量: 261.301
• InChiKey: HPENPQGYBHTTLD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  85.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-methylbenzene diazonium 在 potassium permanganate 、 五氯化磷 、 氨 作用下， 生成 o-Carboxamidodiphenylsulfon
  参考文献：
  名称：

  Weedon; Doughty, American Chemical Journal, 1905, vol. 33, p. 417

  摘要：

  DOI：

文献信息

• [EN] CANNABIGEROL DERIVATIVES AND USE THEREOF AS CANNABINOID RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE CANNABIGÉROL ET LEUR UTILISATION EN TANT QUE MODULATEURS DES RÉCEPTEURS CANNABINOÏDES
  申请人：CANOPY GROWTH CORP

  公开号：WO2021102567A1

  公开（公告）日：2021-06-03

  The synthesis of a range of pentylbezene- 1,3-diol compounds of formula I is disclosed. These compounds bind to cannabinoid 1 and 2 receptors (CB1 and CB2), and are thus presumed to be useful in modulating the activity of such receptors. Accordingly, the use of such synthetic cannabinoids in the treatment of various disorders mediated by CB1 and CB2 is contemplated.

  揭示了一系列式I的戊基苯-1,3-二醇化合物的合成。这些化合物与大麻素1和2受体（CB1和CB2）结合，因此被认为在调节这些受体的活性方面是有用的。因此，考虑了在治疗由CB1和CB2介导的各种疾病中使用这种合成大麻素。
• [EN] TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF<br/>[FR] INHIBITEURS DE LA KINASE TRKA, COMPOSITIONS EN CONTENANT ET MÉTHODES ASSOCIÉES
  申请人：MERCK SHARP & DOHME

  公开号：WO2016054807A1

  公开（公告）日：2016-04-14

  The present invention is directed to substituted indole compounds of formula (I) which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, adisease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.

  本发明涉及式(I)的取代吲哚化合物，它们是肌动蛋白相关激酶（Trk）家族蛋白激酶抑制剂，因此在治疗与神经生长因子（NGF）受体TrkA异常活动相关的疼痛、炎症、癌症、再狭窄、动脉粥样硬化、牛皮癣、血栓形成、疾病、紊乱、损伤或与失髓鞘或脱髓鞘相关的疾病或紊乱方面具有用处。
• [EN] LSD1 INHIBITORS<br/>[FR] INHIBITEURS DE LSD1
  申请人：MIRATI THERAPEUTICS INC

  公开号：WO2017079476A1

  公开（公告）日：2017-05-11

  The present invention relates to compounds that inhibit LSD1 activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

  本发明涉及抑制LSD1活性的化合物。具体而言，本发明涉及化合物、药物组合物和使用方法，例如使用本发明的化合物和药物组合物治疗癌症的方法。
• Chemical Compounds
  申请人：Bell Andrew Simon

  公开号：US20120010207A1

  公开（公告）日：2012-01-12

  The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein Ar 1 , X, R 1 , R 2 , R 3 , R 4 and R 5 are as defined in the description. Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.

  该发明涉及磺胺类衍生物，它们在医学上的应用，含有它们的组合物，用于它们的制备方法以及用于这些方法的中间体。更具体地，该发明涉及一种新的磺胺类Nav1.7抑制剂，其化学式为(I)：或其药用可接受的盐，其中Ar1、X、R1、R2、R3、R4和R5如描述中所定义。Nav1.7抑制剂在治疗各种疾病，特别是疼痛方面具有潜在的用途。
• [EN] METHODS FOR SYNTHESIZING N-(PHENYLSULFONYL)BENZAMIDE COMPOUNDS AND INTERMEDIATES THEREOF<br/>[FR] PROCÉDÉS DE SYNTHÈSE DE COMPOSÉS DE N-(PHÉNYLSULFONYL)BENZAMIDE ET D'INTERMÉDIAIRES DE CEUX-CI
  申请人：ASCENTAGE PHARMA SUZHOU CO LTD

  公开号：WO2022002178A1

  公开（公告）日：2022-01-06

  Disclosed is a method for synthesizing N-(phenylsulfonyl) benzamide compound and intermediate thereof. The method comprises a method for synthesizing a compound 1, comprising conducting a Buchwald-Hartwig coupling reaction as shown below with compound A and compound B in a solvent and in the presence of a base and a palladium catalyst to obtain the compound 1; wherein R is C1-C8 alkyl. The present disclosure synthesizes three intermediate compounds required by the target compound and their preparation methods for the first time. Using the method disclosed in the present disclosure to synthesize the target compound 3 has the advantages of high yield, good purity, easy-to-obtain reaction raw materials, suitable for industrial production.

  揭示了一种合成N-(苯磺酰基)苯甲酰胺化合物及其中间体的方法。该方法包括合成化合物1的方法，包括在溶剂中，在碱和钯催化剂的存在下，通过进行如下所示的Buchwald-Hartwig偶联反应，用化合物A和化合物B来获得化合物1；其中R是C1-C8烷基。本公开揭示了首次合成目标化合物所需的三种中间体化合物及其制备方法。利用本公开揭示的方法合成目标化合物3具有高产率、良好纯度、易得的反应原料、适合工业生产的优点。